BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Nagino M, Hayakawa N. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg. 1993;17:653-657. [PMID: 8273388 DOI: 10.1007/bf01659134] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224:628-38. [PMID: 8916878 DOI: 10.1097/00000658-199611000-00007] [Cited by in Crossref: 219] [Cited by in F6Publishing: 186] [Article Influence: 8.4] [Reference Citation Analysis]
2 Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663-671. [PMID: 10561090 DOI: 10.1097/00000658-199911000-00008] [Cited by in Crossref: 254] [Cited by in F6Publishing: 223] [Article Influence: 11.0] [Reference Citation Analysis]
3 Hui AM, Cui X, Makuuchi M, Li X, Shi YZ, Takayama T. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hepatology 1999;30:1167-73. [PMID: 10534337 DOI: 10.1002/hep.510300506] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
4 Lee SJ, Hwang S, Ha TY, Kim KH, Ahn CS, Moon DB, Song GW, Jung DH, Park GC, Lee SG. Technical knacks and outcomes of extended extrahepatic bile duct resection in patients with mid bile duct cancer. Korean J Hepatobiliary Pancreat Surg 2013;17:109-12. [PMID: 26155223 DOI: 10.14701/kjhbps.2013.17.3.109] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ, P'eng FK. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223:384-394. [PMID: 8633917 DOI: 10.1097/00000658-199604000-00007] [Cited by in Crossref: 187] [Cited by in F6Publishing: 173] [Article Influence: 7.2] [Reference Citation Analysis]
6 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
7 Shiraki T, Kuroda H, Takada A, Nakazato Y, Kubota K, Imai Y. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma. World J Gastroenterol 2018; 24(12): 1332-1342 [PMID: 29599608 DOI: 10.3748/wjg.v24.i12.1332] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ebata T, Nagino M, Nishio H, Igami T, Yokoyama Y, Nimura Y. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 2007;31:2008-15. [PMID: 17661132 DOI: 10.1007/s00268-007-9173-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
9 Khan J, Ullah A, Matolo N, Waheed A, Nama N, Khan T, Tareen B, Khan Z, Singh SG, Cason FD. Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012). Cureus 2021;13:e18941. [PMID: 34815893 DOI: 10.7759/cureus.18941] [Reference Citation Analysis]
10 Cha JM, Kim MH, Jang SJ. Early bile duct cancer. World J Gastroenterol 2007; 13(25): 3409-3416 [PMID: 17659686 DOI: 10.3748/wjg.v13.i25.3409] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
11 Gonzalez RS, Bagci P, Basturk O, Reid MD, Balci S, Knight JH, Kong SY, Memis B, Jang KT, Ohike N, Tajiri T, Bandyopadhyay S, Krasinskas AM, Kim GE, Cheng JD, Adsay NV. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Mod Pathol 2016;29:1358-69. [PMID: 27469329 DOI: 10.1038/modpathol.2016.125] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
12 Lee HG, Lee SH, Yoo DD, Paik KY, Heo JS, Choi SH, Choi DW. Carcinoma of the middle bile duct: Is bile duct segmental resection appropriate? World J Gastroenterol 2009; 15(47): 5966-5971 [PMID: 20014461 DOI: 10.3748/wjg.15.5966] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
13 Chan C, Herrera MF, de la Garza L, Quintanilla-Martinez L, Vargas-Vorackova F, Richaud-Patín Y, Llorente L, Uscanga L, Robles-Diaz G, Leon E. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 1995;222:632-7. [PMID: 7487210 DOI: 10.1097/00000658-199511000-00005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
14 Yamaguchi K, Shirahane K, Nakamura M, Su D, Konomi H, Motoyama K, Sugitani A, Mizumoto K, Tanaka M. Frozen section and permanent diagnoses of the bile duct margin in gallbladder and bile duct cancer. HPB (Oxford). 2005;7:135-138. [PMID: 18333177 DOI: 10.1080/13651820510028873] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
15 Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 2003;27:680-684. [PMID: 12733000 DOI: 10.1007/s00268-003-6656-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shirai K, Ebata T, Oda K, Nishio H, Nagasaka T, Nimura Y, Nagino M. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2008;32:2395-2402. [PMID: 18795245 DOI: 10.1007/s00268-008-9726-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. [PMID: 11224627 DOI: 10.1097/00000658-200103000-00013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 194] [Article Influence: 10.6] [Reference Citation Analysis]
18 Ueda J, Yoshida H, Mamada Y, Taniai N, Yoshioka M, Hirakata A, Kawano Y, Mizuguchi Y, Shimizu T, Kanda T, Takata H, Kondo R, Uchida E. Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination. Oncol Lett 2018;16:6677-84. [PMID: 30405808 DOI: 10.3892/ol.2018.9479] [Reference Citation Analysis]
19 Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, Miyachi M, Uesaka K. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405-411. [PMID: 9527064 DOI: 10.1097/00000658-199803000-00013] [Cited by in Crossref: 200] [Cited by in F6Publishing: 171] [Article Influence: 8.3] [Reference Citation Analysis]
20 Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Cho CK. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today. 2014;44:1879-1886. [PMID: 24535697 DOI: 10.1007/s00595-014-0846-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ehrenfried JA, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol 1999;15:430-5. [PMID: 17023985 DOI: 10.1097/00001574-199909000-00010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Yokoyama Y, Nishio H, Ebata T, Abe T, Igami T, Oda K, Nimura Y, Nagino M. New classification of cystic duct carcinoma. World J Surg. 2008;32:621-626. [PMID: 18224484 DOI: 10.1007/s00268-007-9324-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
23 Ding G, Yang J, Cheng S, Gong H, Liu K, Dai B, Gong B, Zhao L, Cong W, Wu M. Hilar cholangiocarcinoma with synchronous metastases to breast and skeletal muscle: A case report and literature review. Chinese German J Clin Oncol 2006;5:216-8. [DOI: 10.1007/s10330-006-0467-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]